Eric Keller
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology, Interventional | 15 | 2023 | 49 | 6.680 |
Why?
| | Radiologists | 10 | 2024 | 61 | 4.220 |
Why?
| | Radiography, Interventional | 7 | 2020 | 128 | 3.710 |
Why?
| | Informed Consent | 6 | 2023 | 195 | 2.280 |
Why?
| | Specialization | 5 | 2024 | 137 | 2.030 |
Why?
| | Interdisciplinary Communication | 5 | 2019 | 200 | 1.270 |
Why?
| | Medical Futility | 3 | 2020 | 32 | 1.260 |
Why?
| | Leiomyoma | 2 | 2022 | 62 | 1.150 |
Why?
| | Uterine Neoplasms | 2 | 2022 | 98 | 1.110 |
Why?
| | Competitive Behavior | 2 | 2019 | 42 | 1.080 |
Why?
| | Conflict of Interest | 4 | 2024 | 55 | 1.070 |
Why?
| | Embolization, Therapeutic | 2 | 2022 | 246 | 0.990 |
Why?
| | Attitude of Health Personnel | 8 | 2020 | 1219 | 0.980 |
Why?
| | Physicians | 5 | 2021 | 955 | 0.970 |
Why?
| | Practice Patterns, Physicians' | 3 | 2022 | 1408 | 0.870 |
Why?
| | Uterine Myomectomy | 2 | 2022 | 7 | 0.830 |
Why?
| | Hysterectomy | 2 | 2022 | 139 | 0.770 |
Why?
| | Academic Medical Centers | 4 | 2019 | 561 | 0.740 |
Why?
| | Imaging, Three-Dimensional | 2 | 2016 | 582 | 0.730 |
Why?
| | Cyclobutanes | 1 | 2022 | 7 | 0.710 |
Why?
| | Truth Disclosure | 2 | 2020 | 51 | 0.710 |
Why?
| | Education, Medical | 4 | 2023 | 274 | 0.700 |
Why?
| | Colitis, Ulcerative | 1 | 2022 | 143 | 0.630 |
Why?
| | Ethics, Research | 1 | 2020 | 33 | 0.620 |
Why?
| | Perception | 2 | 2020 | 373 | 0.620 |
Why?
| | Health Literacy | 1 | 2022 | 183 | 0.610 |
Why?
| | Quality Indicators, Health Care | 2 | 2020 | 343 | 0.590 |
Why?
| | Endovascular Procedures | 3 | 2024 | 390 | 0.590 |
Why?
| | Ethics, Clinical | 1 | 2019 | 9 | 0.590 |
Why?
| | Compensation and Redress | 1 | 2019 | 8 | 0.590 |
Why?
| | Stents | 3 | 2020 | 554 | 0.590 |
Why?
| | Vascular Diseases | 2 | 2020 | 252 | 0.580 |
Why?
| | Health Facility Administrators | 1 | 2019 | 6 | 0.580 |
Why?
| | Work Engagement | 1 | 2019 | 14 | 0.580 |
Why?
| | Global Health | 1 | 2022 | 403 | 0.570 |
Why?
| | Anatomic Landmarks | 1 | 2019 | 31 | 0.570 |
Why?
| | Job Description | 1 | 2018 | 10 | 0.570 |
Why?
| | Enediynes | 1 | 2018 | 1 | 0.550 |
Why?
| | Image-Guided Biopsy | 1 | 2018 | 41 | 0.550 |
Why?
| | Vascular Access Devices | 1 | 2018 | 30 | 0.550 |
Why?
| | Veins | 1 | 2018 | 68 | 0.540 |
Why?
| | Occupational Stress | 1 | 2019 | 47 | 0.540 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 174 | 0.530 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2017 | 295 | 0.520 |
Why?
| | Referral and Consultation | 3 | 2022 | 881 | 0.520 |
Why?
| | Hypersplenism | 1 | 2017 | 9 | 0.510 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 116 | 0.510 |
Why?
| | Ultrasonography, Interventional | 1 | 2019 | 163 | 0.510 |
Why?
| | Humans | 46 | 2024 | 146342 | 0.500 |
Why?
| | Organometallic Compounds | 1 | 2018 | 110 | 0.500 |
Why?
| | Splenic Vein | 1 | 2016 | 2 | 0.500 |
Why?
| | Palliative Care | 3 | 2022 | 1032 | 0.500 |
Why?
| | Splanchnic Circulation | 1 | 2016 | 11 | 0.500 |
Why?
| | Radiation Dosage | 1 | 2018 | 193 | 0.490 |
Why?
| | Splenic Artery | 1 | 2016 | 13 | 0.490 |
Why?
| | Cardiac Imaging Techniques | 1 | 2016 | 24 | 0.480 |
Why?
| | Terminology as Topic | 1 | 2018 | 253 | 0.480 |
Why?
| | Perfusion Imaging | 1 | 2016 | 66 | 0.480 |
Why?
| | Intersectoral Collaboration | 1 | 2017 | 64 | 0.480 |
Why?
| | Patient Care Team | 2 | 2019 | 701 | 0.480 |
Why?
| | Arteriovenous Fistula | 1 | 2016 | 36 | 0.480 |
Why?
| | Interprofessional Relations | 1 | 2019 | 275 | 0.480 |
Why?
| | Patients | 1 | 2018 | 183 | 0.470 |
Why?
| | Abdomen | 1 | 2016 | 142 | 0.460 |
Why?
| | Magnetic Resonance Imaging | 3 | 2017 | 3926 | 0.460 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2019 | 1408 | 0.450 |
Why?
| | Professional Role | 1 | 2017 | 172 | 0.450 |
Why?
| | Myocardial Contraction | 1 | 2017 | 292 | 0.450 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2017 | 214 | 0.450 |
Why?
| | Electrocardiography | 1 | 2019 | 667 | 0.450 |
Why?
| | Health Care Costs | 1 | 2019 | 423 | 0.450 |
Why?
| | Workflow | 1 | 2016 | 182 | 0.440 |
Why?
| | Temperature | 1 | 2018 | 635 | 0.440 |
Why?
| | Spleen | 1 | 2017 | 503 | 0.430 |
Why?
| | Liver Cirrhosis | 1 | 2017 | 278 | 0.430 |
Why?
| | Medical Oncology | 1 | 2018 | 345 | 0.430 |
Why?
| | Heart Valve Prosthesis | 1 | 2016 | 127 | 0.420 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 249 | 0.420 |
Why?
| | Catheter Ablation | 1 | 2018 | 355 | 0.420 |
Why?
| | Patient Preference | 1 | 2017 | 226 | 0.410 |
Why?
| | Gynecology | 1 | 2017 | 185 | 0.410 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2014 | 15 | 0.410 |
Why?
| | Hemodynamics | 2 | 2017 | 1114 | 0.410 |
Why?
| | Internship and Residency | 2 | 2023 | 1281 | 0.400 |
Why?
| | Ambulatory Care | 1 | 2019 | 628 | 0.400 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 391 | 0.390 |
Why?
| | Health Policy | 1 | 2017 | 399 | 0.390 |
Why?
| | Liver Diseases | 1 | 2016 | 304 | 0.390 |
Why?
| | Aorta, Thoracic | 1 | 2016 | 284 | 0.390 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 541 | 0.390 |
Why?
| | Biomedical Research | 1 | 2020 | 729 | 0.390 |
Why?
| | Vascular Surgical Procedures | 1 | 2017 | 352 | 0.390 |
Why?
| | Female | 23 | 2022 | 79499 | 0.380 |
Why?
| | Aorta | 1 | 2016 | 440 | 0.380 |
Why?
| | Aortic Valve | 1 | 2016 | 360 | 0.380 |
Why?
| | Interviews as Topic | 4 | 2018 | 930 | 0.370 |
Why?
| | Fellowships and Scholarships | 1 | 2017 | 355 | 0.370 |
Why?
| | Quality of Health Care | 1 | 2018 | 702 | 0.370 |
Why?
| | End Stage Liver Disease | 1 | 2013 | 84 | 0.360 |
Why?
| | Adipocytes | 1 | 2014 | 223 | 0.360 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2015 | 191 | 0.360 |
Why?
| | Paracentesis | 2 | 2022 | 16 | 0.360 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 778 | 0.350 |
Why?
| | Surgeons | 1 | 2017 | 351 | 0.350 |
Why?
| | Predictive Value of Tests | 4 | 2019 | 2113 | 0.340 |
Why?
| | Male | 19 | 2022 | 73396 | 0.340 |
Why?
| | Software | 1 | 2017 | 676 | 0.340 |
Why?
| | Melanoma | 1 | 2018 | 765 | 0.340 |
Why?
| | Quality Improvement | 1 | 2020 | 1354 | 0.320 |
Why?
| | Adult | 13 | 2022 | 41087 | 0.310 |
Why?
| | Physician-Patient Relations | 3 | 2020 | 597 | 0.310 |
Why?
| | Tissue and Organ Procurement | 1 | 2013 | 305 | 0.300 |
Why?
| | Delivery of Health Care | 1 | 2017 | 947 | 0.300 |
Why?
| | Middle Aged | 12 | 2022 | 36619 | 0.300 |
Why?
| | Public-Private Sector Partnerships | 2 | 2020 | 45 | 0.290 |
Why?
| | Decision Making | 1 | 2017 | 993 | 0.290 |
Why?
| | Diffusion of Innovation | 2 | 2020 | 96 | 0.290 |
Why?
| | Students, Medical | 1 | 2014 | 383 | 0.280 |
Why?
| | Time Factors | 6 | 2020 | 7109 | 0.280 |
Why?
| | Computed Tomography Angiography | 3 | 2019 | 151 | 0.270 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2786 | 0.260 |
Why?
| | Policy Making | 2 | 2019 | 83 | 0.260 |
Why?
| | Mental Health | 1 | 2014 | 779 | 0.250 |
Why?
| | Liver Transplantation | 1 | 2013 | 751 | 0.240 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2219 | 0.240 |
Why?
| | Cell Differentiation | 1 | 2014 | 1982 | 0.240 |
Why?
| | Trust | 2 | 2019 | 160 | 0.230 |
Why?
| | Ascites | 2 | 2022 | 48 | 0.220 |
Why?
| | Cooperative Behavior | 2 | 2019 | 471 | 0.220 |
Why?
| | Lung | 1 | 2018 | 4122 | 0.220 |
Why?
| | Vascular Patency | 3 | 2020 | 115 | 0.210 |
Why?
| | Retrospective Studies | 10 | 2022 | 17438 | 0.210 |
Why?
| | Health Care Sector | 2 | 2024 | 25 | 0.210 |
Why?
| | Clinical Decision-Making | 2 | 2019 | 365 | 0.210 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 6073 | 0.200 |
Why?
| | Aged | 7 | 2022 | 26432 | 0.190 |
Why?
| | Cost-Benefit Analysis | 3 | 2022 | 640 | 0.190 |
Why?
| | Resuscitation Orders | 1 | 2022 | 48 | 0.180 |
Why?
| | Treatment Outcome | 5 | 2019 | 11821 | 0.180 |
Why?
| | Prospective Studies | 3 | 2022 | 8123 | 0.180 |
Why?
| | Phlebography | 2 | 2019 | 38 | 0.180 |
Why?
| | Chicago | 2 | 2019 | 62 | 0.180 |
Why?
| | Social Media | 1 | 2024 | 159 | 0.170 |
Why?
| | Constriction, Pathologic | 2 | 2020 | 240 | 0.170 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2022 | 122 | 0.160 |
Why?
| | Testosterone | 2 | 2015 | 419 | 0.160 |
Why?
| | Radiology | 1 | 2023 | 175 | 0.160 |
Why?
| | Patient Care Planning | 1 | 2022 | 170 | 0.160 |
Why?
| | Superior Vena Cava Syndrome | 1 | 2020 | 4 | 0.160 |
Why?
| | Genital Neoplasms, Female | 1 | 2022 | 100 | 0.160 |
Why?
| | Vena Cava, Superior | 1 | 2020 | 25 | 0.160 |
Why?
| | United States | 6 | 2024 | 16136 | 0.150 |
Why?
| | May-Thurner Syndrome | 1 | 2019 | 2 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1591 | 0.150 |
Why?
| | Iliac Vein | 1 | 2019 | 13 | 0.150 |
Why?
| | Vena Cava, Inferior | 1 | 2020 | 80 | 0.150 |
Why?
| | Angioplasty, Balloon | 1 | 2020 | 92 | 0.150 |
Why?
| | Interinstitutional Relations | 1 | 2019 | 56 | 0.140 |
Why?
| | Culturally Competent Care | 1 | 2020 | 66 | 0.140 |
Why?
| | Salaries and Fringe Benefits | 1 | 2019 | 57 | 0.140 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2018 | 21 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2017 | 3416 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1133 | 0.140 |
Why?
| | Signal-To-Noise Ratio | 1 | 2018 | 71 | 0.140 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2019 | 102 | 0.140 |
Why?
| | Professional-Family Relations | 1 | 2020 | 158 | 0.140 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2019 | 97 | 0.130 |
Why?
| | Comprehension | 1 | 2020 | 175 | 0.130 |
Why?
| | Decision Support Techniques | 1 | 2022 | 478 | 0.130 |
Why?
| | Hyperthermia, Induced | 1 | 2018 | 119 | 0.130 |
Why?
| | Communication | 2 | 2023 | 980 | 0.120 |
Why?
| | Philosophy, Medical | 1 | 2017 | 9 | 0.120 |
Why?
| | Uterine Artery Embolization | 1 | 2017 | 9 | 0.120 |
Why?
| | Grounded Theory | 1 | 2017 | 47 | 0.120 |
Why?
| | Equipment Design | 1 | 2018 | 520 | 0.120 |
Why?
| | Automation | 1 | 2017 | 104 | 0.120 |
Why?
| | Medicare | 2 | 2022 | 920 | 0.120 |
Why?
| | Interview, Psychological | 1 | 2017 | 94 | 0.120 |
Why?
| | Hypertension, Portal | 1 | 2017 | 66 | 0.120 |
Why?
| | Education, Medical, Graduate | 2 | 2023 | 568 | 0.120 |
Why?
| | Career Choice | 1 | 2018 | 237 | 0.120 |
Why?
| | Echocardiography, Four-Dimensional | 1 | 2016 | 9 | 0.120 |
Why?
| | Patient Safety | 1 | 2020 | 352 | 0.120 |
Why?
| | Observer Variation | 1 | 2017 | 356 | 0.120 |
Why?
| | Risk Assessment | 3 | 2020 | 3712 | 0.110 |
Why?
| | DNA Repair | 1 | 2018 | 255 | 0.110 |
Why?
| | Image Enhancement | 1 | 2016 | 198 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2016 | 218 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 379 | 0.110 |
Why?
| | DNA Damage | 1 | 2018 | 439 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2018 | 8391 | 0.110 |
Why?
| | Blood Flow Velocity | 1 | 2016 | 419 | 0.110 |
Why?
| | Embryonic Development | 1 | 2015 | 124 | 0.110 |
Why?
| | Stress, Mechanical | 1 | 2017 | 497 | 0.110 |
Why?
| | Empathy | 1 | 2017 | 184 | 0.110 |
Why?
| | PPAR delta | 1 | 2014 | 6 | 0.100 |
Why?
| | Regional Blood Flow | 1 | 2016 | 507 | 0.100 |
Why?
| | Leadership | 1 | 2019 | 414 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2014 | 17 | 0.100 |
Why?
| | ROC Curve | 1 | 2016 | 617 | 0.100 |
Why?
| | Zinc Fingers | 1 | 2014 | 50 | 0.100 |
Why?
| | Adipogenesis | 1 | 2014 | 56 | 0.100 |
Why?
| | Stroke Volume | 1 | 2017 | 652 | 0.100 |
Why?
| | Emergency Medical Services | 1 | 2020 | 680 | 0.100 |
Why?
| | Contrast Media | 1 | 2016 | 493 | 0.100 |
Why?
| | Macaca mulatta | 1 | 2014 | 188 | 0.100 |
Why?
| | Biomechanical Phenomena | 1 | 2017 | 874 | 0.100 |
Why?
| | Young Adult | 2 | 2022 | 14330 | 0.100 |
Why?
| | Geography | 1 | 2013 | 187 | 0.100 |
Why?
| | Ethics, Medical | 1 | 2013 | 90 | 0.090 |
Why?
| | PPAR gamma | 1 | 2014 | 182 | 0.090 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 279 | 0.090 |
Why?
| | Androgens | 1 | 2014 | 179 | 0.090 |
Why?
| | Disclosure | 2 | 2024 | 91 | 0.090 |
Why?
| | Patient Selection | 1 | 2016 | 728 | 0.090 |
Why?
| | Laparoscopy | 1 | 2017 | 487 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 974 | 0.090 |
Why?
| | Curriculum | 1 | 2019 | 1079 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2016 | 594 | 0.090 |
Why?
| | Waiting Lists | 1 | 2013 | 251 | 0.090 |
Why?
| | Catheters, Indwelling | 2 | 2022 | 94 | 0.080 |
Why?
| | Pilot Projects | 1 | 2017 | 1888 | 0.080 |
Why?
| | Adiposity | 1 | 2015 | 533 | 0.080 |
Why?
| | Qualitative Research | 1 | 2019 | 1734 | 0.080 |
Why?
| | Survival Analysis | 1 | 2013 | 1378 | 0.080 |
Why?
| | Risk Factors | 3 | 2020 | 10921 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3545 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 669 | 0.070 |
Why?
| | Gene Expression | 1 | 2014 | 1463 | 0.070 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2015 | 665 | 0.070 |
Why?
| | Clinical Competence | 1 | 2017 | 1272 | 0.070 |
Why?
| | Liver | 1 | 2016 | 1864 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5899 | 0.060 |
Why?
| | Insulin Resistance | 1 | 2015 | 1247 | 0.060 |
Why?
| | Age Factors | 1 | 2013 | 3347 | 0.060 |
Why?
| | Transcription Factors | 1 | 2014 | 1730 | 0.060 |
Why?
| | Algorithms | 1 | 2013 | 1849 | 0.060 |
Why?
| | Neoplasms | 1 | 2020 | 2954 | 0.050 |
Why?
| | Neurosurgeons | 1 | 2024 | 17 | 0.050 |
Why?
| | Quality of Life | 1 | 2013 | 3200 | 0.040 |
Why?
| | Death | 1 | 2022 | 129 | 0.040 |
Why?
| | First Aid | 1 | 2020 | 11 | 0.040 |
Why?
| | Bolivia | 1 | 2020 | 64 | 0.040 |
Why?
| | Moral Obligations | 1 | 2020 | 15 | 0.040 |
Why?
| | Patient Care | 1 | 2021 | 120 | 0.040 |
Why?
| | Social Justice | 1 | 2020 | 83 | 0.040 |
Why?
| | Retreatment | 1 | 2019 | 79 | 0.040 |
Why?
| | Treatment Failure | 1 | 2020 | 361 | 0.040 |
Why?
| | Needs Assessment | 1 | 2020 | 404 | 0.030 |
Why?
| | Occupational Health | 1 | 2020 | 212 | 0.030 |
Why?
| | Adolescent | 1 | 2017 | 22557 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.030 |
Why?
| | Flutamide | 1 | 2015 | 7 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 738 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1493 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2861 | 0.030 |
Why?
| | Animals | 2 | 2015 | 38107 | 0.030 |
Why?
| | Thiazolidinediones | 1 | 2015 | 142 | 0.030 |
Why?
| | Sheep | 1 | 2015 | 870 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1707 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4580 | 0.010 |
Why?
| | Pregnancy | 1 | 2015 | 7230 | 0.010 |
Why?
| | Obesity | 1 | 2015 | 3131 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|